Sodium in PDB 5vu0: Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans
Protein crystallography data
The structure of Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans, PDB code: 5vu0
was solved by
G.S.Subedi,
A.M.Marcella,
A.W.Barb,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
10.00 /
2.26
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
124.069,
48.846,
134.927,
90.00,
103.77,
90.00
|
R / Rfree (%)
|
19.2 /
23.7
|
Sodium Binding Sites:
The binding sites of Sodium atom in the Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans
(pdb code 5vu0). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 9 binding sites of Sodium where determined in the
Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans, PDB code: 5vu0:
Jump to Sodium binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
9;
Sodium binding site 1 out
of 9 in 5vu0
Go back to
Sodium Binding Sites List in 5vu0
Sodium binding site 1 out
of 9 in the Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na1014
b:44.0
occ:1.00
|
OE1
|
A:GLU357
|
2.8
|
43.2
|
1.0
|
N
|
A:SER354
|
3.2
|
42.5
|
1.0
|
NA
|
A:NA1018
|
3.3
|
41.0
|
1.0
|
CD
|
A:GLU357
|
3.6
|
45.6
|
1.0
|
CA
|
A:PRO353
|
3.6
|
41.7
|
1.0
|
CD2
|
B:LEU368
|
3.7
|
29.9
|
1.0
|
CB
|
A:SER354
|
3.8
|
47.2
|
1.0
|
CD2
|
B:LEU351
|
3.9
|
40.5
|
1.0
|
O
|
A:SER364
|
3.9
|
31.4
|
1.0
|
C
|
A:PRO353
|
3.9
|
42.0
|
1.0
|
CB
|
A:SER364
|
4.0
|
32.1
|
1.0
|
CB
|
B:TYR349
|
4.0
|
32.8
|
1.0
|
CA
|
A:SER354
|
4.1
|
45.0
|
1.0
|
OE2
|
A:GLU357
|
4.2
|
43.6
|
1.0
|
CG
|
B:TYR349
|
4.2
|
33.6
|
1.0
|
CB
|
A:PRO353
|
4.3
|
42.5
|
1.0
|
CB
|
A:GLU357
|
4.3
|
48.9
|
1.0
|
CD2
|
B:TYR349
|
4.4
|
33.5
|
1.0
|
CG
|
A:GLU357
|
4.5
|
47.6
|
1.0
|
OG
|
A:SER364
|
4.6
|
32.5
|
1.0
|
O
|
A:PRO352
|
4.6
|
35.4
|
1.0
|
C
|
A:SER364
|
4.7
|
31.7
|
1.0
|
CA
|
A:SER364
|
4.7
|
32.8
|
1.0
|
N
|
A:PRO353
|
4.8
|
40.3
|
1.0
|
N
|
A:SER364
|
4.8
|
34.5
|
1.0
|
CG
|
B:LEU351
|
4.9
|
39.4
|
1.0
|
CD1
|
B:TYR349
|
4.9
|
34.4
|
1.0
|
CG
|
B:LEU368
|
4.9
|
28.9
|
1.0
|
CD1
|
B:LEU351
|
4.9
|
39.3
|
1.0
|
|
Sodium binding site 2 out
of 9 in 5vu0
Go back to
Sodium Binding Sites List in 5vu0
Sodium binding site 2 out
of 9 in the Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na1015
b:38.8
occ:1.00
|
O
|
A:TRP313
|
2.7
|
29.6
|
1.0
|
O
|
A:LYS317
|
2.7
|
32.8
|
1.0
|
N
|
A:LYS338
|
3.1
|
35.2
|
1.0
|
CA
|
A:GLY316
|
3.4
|
37.6
|
1.0
|
N
|
A:LYS317
|
3.4
|
37.2
|
1.0
|
C
|
A:GLY316
|
3.4
|
37.2
|
1.0
|
CB
|
A:LYS338
|
3.5
|
40.0
|
1.0
|
C
|
A:TRP313
|
3.6
|
31.5
|
1.0
|
CA
|
A:SER337
|
3.7
|
36.1
|
1.0
|
CE3
|
A:TRP313
|
3.7
|
29.9
|
1.0
|
CD2
|
A:TRP313
|
3.7
|
29.3
|
1.0
|
CB
|
A:SER337
|
3.8
|
37.2
|
1.0
|
CA
|
A:TRP313
|
3.8
|
30.6
|
1.0
|
C
|
A:LYS317
|
3.8
|
36.2
|
1.0
|
N
|
A:GLY316
|
3.8
|
37.1
|
1.0
|
C
|
A:SER337
|
3.9
|
34.8
|
1.0
|
CA
|
A:LYS338
|
3.9
|
36.0
|
1.0
|
O
|
A:GLY316
|
4.0
|
39.5
|
1.0
|
CG
|
A:TRP313
|
4.1
|
29.3
|
1.0
|
CZ3
|
A:TRP313
|
4.2
|
30.2
|
1.0
|
CA
|
A:LYS317
|
4.2
|
36.4
|
1.0
|
CE2
|
A:TRP313
|
4.2
|
29.5
|
1.0
|
O
|
A:ASP312
|
4.2
|
35.3
|
1.0
|
CE1
|
A:TYR319
|
4.5
|
34.8
|
1.0
|
CB
|
A:TRP313
|
4.5
|
29.1
|
1.0
|
CH2
|
A:TRP313
|
4.6
|
29.3
|
1.0
|
CZ2
|
A:TRP313
|
4.7
|
29.2
|
1.0
|
CD1
|
A:TRP313
|
4.7
|
29.9
|
1.0
|
CD1
|
A:TYR319
|
4.8
|
33.0
|
1.0
|
NE1
|
A:TRP313
|
4.8
|
29.0
|
1.0
|
N
|
A:TRP313
|
4.8
|
31.5
|
1.0
|
N
|
A:LEU314
|
4.8
|
32.4
|
1.0
|
CG
|
A:LYS338
|
4.9
|
45.4
|
1.0
|
C
|
A:ASP312
|
4.9
|
34.4
|
1.0
|
N
|
A:GLU318
|
4.9
|
37.4
|
1.0
|
OG
|
A:SER337
|
5.0
|
37.5
|
1.0
|
CB
|
A:LYS317
|
5.0
|
37.2
|
1.0
|
|
Sodium binding site 3 out
of 9 in 5vu0
Go back to
Sodium Binding Sites List in 5vu0
Sodium binding site 3 out
of 9 in the Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 3 of Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na1016
b:36.3
occ:1.00
|
OD1
|
A:ASN325
|
2.8
|
33.3
|
1.0
|
NE2
|
C:HIS134
|
2.9
|
41.6
|
1.0
|
O
|
A:ASP270
|
3.0
|
42.3
|
1.0
|
OG
|
A:SER267
|
3.1
|
35.2
|
1.0
|
N
|
A:SER267
|
3.4
|
32.0
|
1.0
|
CE1
|
C:HIS134
|
3.6
|
41.1
|
1.0
|
CG
|
A:ASN325
|
3.6
|
34.5
|
1.0
|
CB
|
A:ALA327
|
3.7
|
44.8
|
1.0
|
ND2
|
A:ASN325
|
3.7
|
33.8
|
1.0
|
CB
|
A:ASP270
|
3.8
|
46.4
|
1.0
|
C
|
A:ASP270
|
3.9
|
43.8
|
1.0
|
CG
|
A:PRO238
|
3.9
|
43.7
|
1.0
|
CB
|
A:SER267
|
4.0
|
34.7
|
1.0
|
CA
|
A:VAL266
|
4.0
|
31.1
|
1.0
|
O
|
A:HOH1104
|
4.1
|
36.6
|
1.0
|
CD2
|
C:HIS134
|
4.1
|
41.2
|
1.0
|
CG1
|
A:VAL266
|
4.1
|
31.5
|
1.0
|
C
|
A:VAL266
|
4.2
|
31.7
|
1.0
|
CA
|
A:SER267
|
4.2
|
33.0
|
1.0
|
CD
|
A:PRO238
|
4.3
|
44.3
|
1.0
|
CA
|
A:ASP270
|
4.3
|
45.3
|
1.0
|
O
|
A:SER267
|
4.4
|
33.0
|
1.0
|
N
|
A:ASP270
|
4.6
|
46.2
|
1.0
|
CB
|
A:VAL266
|
4.6
|
31.2
|
1.0
|
N
|
A:ALA327
|
4.6
|
45.3
|
1.0
|
O
|
A:ASP265
|
4.6
|
29.5
|
1.0
|
C
|
A:SER267
|
4.8
|
33.8
|
1.0
|
CA
|
A:ALA327
|
4.8
|
45.8
|
1.0
|
ND1
|
C:HIS134
|
4.9
|
41.0
|
1.0
|
CG
|
A:ASP270
|
5.0
|
48.1
|
1.0
|
N
|
A:PRO271
|
5.0
|
43.7
|
1.0
|
|
Sodium binding site 4 out
of 9 in 5vu0
Go back to
Sodium Binding Sites List in 5vu0
Sodium binding site 4 out
of 9 in the Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 4 of Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na1017
b:34.6
occ:1.00
|
O
|
A:ASN421
|
2.6
|
40.4
|
1.0
|
O
|
A:TRP417
|
2.8
|
47.4
|
1.0
|
N
|
A:ASN421
|
3.1
|
47.7
|
1.0
|
C
|
A:GLY420
|
3.2
|
49.2
|
1.0
|
N
|
A:LEU443
|
3.2
|
50.3
|
1.0
|
CA
|
A:GLY420
|
3.3
|
50.6
|
1.0
|
C
|
A:ASN421
|
3.5
|
42.0
|
1.0
|
N
|
A:GLY420
|
3.6
|
52.3
|
1.0
|
CE3
|
A:TRP417
|
3.7
|
39.8
|
1.0
|
CB
|
A:LEU443
|
3.7
|
57.0
|
1.0
|
C
|
A:TRP417
|
3.7
|
48.1
|
1.0
|
O
|
A:GLY420
|
3.8
|
48.0
|
1.0
|
CA
|
A:ASN421
|
3.8
|
45.9
|
1.0
|
CA
|
A:SER442
|
3.9
|
47.8
|
1.0
|
C
|
A:SER442
|
4.0
|
48.5
|
1.0
|
CA
|
A:TRP417
|
4.0
|
43.6
|
1.0
|
CB
|
A:SER442
|
4.0
|
48.9
|
1.0
|
CA
|
A:LEU443
|
4.0
|
54.4
|
1.0
|
CZ3
|
A:TRP417
|
4.1
|
38.4
|
1.0
|
CD2
|
A:TRP417
|
4.1
|
39.9
|
1.0
|
O
|
A:ARG416
|
4.2
|
45.5
|
1.0
|
CE2
|
A:PHE423
|
4.6
|
34.1
|
1.0
|
CG
|
A:TRP417
|
4.6
|
40.6
|
1.0
|
CB
|
A:ASN421
|
4.7
|
45.2
|
1.0
|
N
|
A:VAL422
|
4.7
|
40.7
|
1.0
|
CE2
|
A:TRP417
|
4.7
|
39.3
|
1.0
|
CH2
|
A:TRP417
|
4.8
|
38.0
|
1.0
|
CD2
|
A:PHE423
|
4.8
|
33.0
|
1.0
|
C
|
A:GLN419
|
4.8
|
56.2
|
1.0
|
CB
|
A:TRP417
|
4.9
|
41.2
|
1.0
|
O
|
A:HOH1196
|
4.9
|
50.8
|
1.0
|
N
|
A:GLN418
|
5.0
|
51.1
|
1.0
|
|
Sodium binding site 5 out
of 9 in 5vu0
Go back to
Sodium Binding Sites List in 5vu0
Sodium binding site 5 out
of 9 in the Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 5 of Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na1018
b:41.0
occ:1.00
|
OG1
|
A:THR366
|
2.6
|
23.1
|
1.0
|
O
|
A:SER364
|
2.7
|
31.4
|
1.0
|
O
|
A:PRO352
|
3.2
|
35.4
|
1.0
|
NA
|
A:NA1014
|
3.3
|
44.0
|
1.0
|
CB
|
A:THR366
|
3.4
|
24.3
|
1.0
|
O
|
A:LEU351
|
3.5
|
34.3
|
1.0
|
C
|
A:SER364
|
3.5
|
31.7
|
1.0
|
C
|
A:PRO352
|
3.6
|
38.1
|
1.0
|
N
|
A:THR366
|
3.6
|
26.5
|
1.0
|
CD1
|
B:LEU351
|
3.7
|
39.3
|
1.0
|
CA
|
A:PRO353
|
3.8
|
41.7
|
1.0
|
N
|
A:PRO353
|
3.8
|
40.3
|
1.0
|
C
|
A:LEU365
|
4.0
|
27.4
|
1.0
|
CA
|
A:LEU365
|
4.0
|
29.4
|
1.0
|
N
|
A:LEU365
|
4.1
|
30.3
|
1.0
|
CA
|
A:THR366
|
4.1
|
25.0
|
1.0
|
CD2
|
B:LEU351
|
4.1
|
40.5
|
1.0
|
CB
|
A:SER364
|
4.3
|
32.1
|
1.0
|
C
|
A:LEU351
|
4.3
|
35.9
|
1.0
|
CA
|
A:SER364
|
4.5
|
32.8
|
1.0
|
CG
|
B:LEU351
|
4.6
|
39.4
|
1.0
|
CA
|
A:PRO352
|
4.6
|
38.5
|
1.0
|
CB
|
A:LEU351
|
4.7
|
35.8
|
1.0
|
C
|
A:PRO353
|
4.7
|
42.0
|
1.0
|
N
|
A:SER354
|
4.7
|
42.5
|
1.0
|
CG2
|
A:THR366
|
4.8
|
23.7
|
1.0
|
O
|
A:LEU365
|
4.8
|
25.9
|
1.0
|
CD2
|
B:LEU368
|
4.8
|
29.9
|
1.0
|
OH
|
B:TYR407
|
4.9
|
23.6
|
1.0
|
CB
|
A:PRO353
|
4.9
|
42.5
|
1.0
|
N
|
A:PRO352
|
4.9
|
38.2
|
1.0
|
CD
|
A:PRO353
|
4.9
|
41.9
|
1.0
|
OE1
|
A:GLU357
|
5.0
|
43.2
|
1.0
|
|
Sodium binding site 6 out
of 9 in 5vu0
Go back to
Sodium Binding Sites List in 5vu0
Sodium binding site 6 out
of 9 in the Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 6 of Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Na1011
b:40.3
occ:1.00
|
O
|
B:SER364
|
2.6
|
36.9
|
1.0
|
OG1
|
B:THR366
|
2.8
|
30.9
|
1.0
|
O
|
B:PRO352
|
3.1
|
36.5
|
1.0
|
NA
|
B:NA1014
|
3.3
|
39.9
|
1.0
|
CB
|
B:THR366
|
3.5
|
31.1
|
1.0
|
C
|
B:SER364
|
3.5
|
36.1
|
1.0
|
O
|
B:LEU351
|
3.5
|
40.1
|
1.0
|
C
|
B:PRO352
|
3.5
|
39.2
|
1.0
|
N
|
B:THR366
|
3.6
|
32.4
|
1.0
|
CD1
|
A:LEU351
|
3.7
|
35.1
|
1.0
|
CA
|
B:PRO353
|
3.8
|
41.6
|
1.0
|
N
|
B:PRO353
|
3.8
|
40.7
|
1.0
|
CD2
|
A:LEU351
|
3.9
|
35.6
|
1.0
|
C
|
B:LEU365
|
4.1
|
32.6
|
1.0
|
CA
|
B:LEU365
|
4.1
|
35.1
|
1.0
|
CA
|
B:THR366
|
4.2
|
32.0
|
1.0
|
N
|
B:LEU365
|
4.2
|
34.0
|
1.0
|
CB
|
B:SER364
|
4.3
|
36.8
|
1.0
|
C
|
B:LEU351
|
4.4
|
38.5
|
1.0
|
CG
|
A:LEU351
|
4.5
|
34.9
|
1.0
|
CA
|
B:SER364
|
4.5
|
36.8
|
1.0
|
CA
|
B:PRO352
|
4.6
|
39.8
|
1.0
|
N
|
B:SER354
|
4.6
|
45.2
|
1.0
|
C
|
B:PRO353
|
4.6
|
42.7
|
1.0
|
CD
|
B:PRO353
|
4.7
|
42.1
|
1.0
|
CG2
|
B:THR366
|
4.8
|
29.7
|
1.0
|
CD2
|
A:LEU368
|
4.8
|
28.5
|
1.0
|
N
|
B:PRO352
|
4.9
|
39.7
|
1.0
|
CB
|
B:LEU351
|
4.9
|
39.0
|
1.0
|
CB
|
B:PRO353
|
4.9
|
42.3
|
1.0
|
O
|
B:LEU365
|
4.9
|
31.5
|
1.0
|
OE1
|
B:GLU357
|
4.9
|
45.5
|
1.0
|
OH
|
A:TYR407
|
5.0
|
24.8
|
1.0
|
|
Sodium binding site 7 out
of 9 in 5vu0
Go back to
Sodium Binding Sites List in 5vu0
Sodium binding site 7 out
of 9 in the Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 7 of Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Na1012
b:33.5
occ:1.00
|
O
|
B:TRP313
|
2.7
|
28.5
|
1.0
|
O
|
B:LYS317
|
2.8
|
33.2
|
1.0
|
N
|
B:LYS338
|
3.0
|
31.7
|
1.0
|
CA
|
B:GLY316
|
3.3
|
36.6
|
1.0
|
C
|
B:GLY316
|
3.3
|
37.7
|
1.0
|
N
|
B:LYS317
|
3.4
|
38.6
|
1.0
|
CA
|
B:SER337
|
3.5
|
30.3
|
1.0
|
C
|
B:TRP313
|
3.6
|
30.3
|
1.0
|
CB
|
B:SER337
|
3.6
|
30.8
|
1.0
|
N
|
B:GLY316
|
3.6
|
36.7
|
1.0
|
C
|
B:SER337
|
3.7
|
31.3
|
1.0
|
CE3
|
B:TRP313
|
3.8
|
29.3
|
1.0
|
CA
|
B:TRP313
|
3.8
|
30.2
|
1.0
|
C
|
B:LYS317
|
3.8
|
35.6
|
1.0
|
CD2
|
B:TRP313
|
3.9
|
27.9
|
1.0
|
CB
|
B:LYS338
|
3.9
|
34.2
|
1.0
|
CG
|
B:LYS338
|
3.9
|
38.7
|
1.0
|
CA
|
B:LYS338
|
4.0
|
32.2
|
1.0
|
O
|
B:GLY316
|
4.0
|
37.0
|
1.0
|
CA
|
B:LYS317
|
4.2
|
38.2
|
1.0
|
O
|
B:ASP312
|
4.2
|
36.1
|
1.0
|
CZ3
|
B:TRP313
|
4.2
|
28.7
|
1.0
|
CG
|
B:TRP313
|
4.2
|
28.8
|
1.0
|
CE2
|
B:TRP313
|
4.3
|
27.7
|
1.0
|
CE1
|
B:TYR319
|
4.5
|
30.8
|
1.0
|
CH2
|
B:TRP313
|
4.6
|
28.0
|
1.0
|
CB
|
B:TRP313
|
4.6
|
29.5
|
1.0
|
CZ2
|
B:TRP313
|
4.7
|
27.8
|
1.0
|
OG
|
B:SER337
|
4.7
|
30.7
|
1.0
|
N
|
B:LEU314
|
4.8
|
30.6
|
1.0
|
N
|
B:TRP313
|
4.9
|
31.9
|
1.0
|
CD1
|
B:TRP313
|
4.9
|
29.0
|
1.0
|
NE1
|
B:TRP313
|
4.9
|
29.1
|
1.0
|
N
|
B:SER337
|
4.9
|
30.4
|
1.0
|
O
|
B:SER337
|
4.9
|
31.8
|
1.0
|
CD1
|
B:TYR319
|
4.9
|
30.4
|
1.0
|
C
|
B:ASN315
|
4.9
|
36.8
|
1.0
|
C
|
B:ASP312
|
4.9
|
35.5
|
1.0
|
O
|
B:LYS338
|
5.0
|
29.9
|
1.0
|
N
|
B:GLU318
|
5.0
|
34.5
|
1.0
|
C
|
B:LYS338
|
5.0
|
29.9
|
1.0
|
|
Sodium binding site 8 out
of 9 in 5vu0
Go back to
Sodium Binding Sites List in 5vu0
Sodium binding site 8 out
of 9 in the Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 8 of Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Na1013
b:46.7
occ:1.00
|
O
|
B:ASN421
|
2.6
|
53.7
|
1.0
|
O
|
B:TRP417
|
2.7
|
52.5
|
1.0
|
N
|
B:LEU443
|
3.3
|
66.3
|
1.0
|
C
|
B:GLY420
|
3.3
|
63.6
|
1.0
|
N
|
B:ASN421
|
3.4
|
62.2
|
1.0
|
CA
|
B:GLY420
|
3.4
|
66.5
|
1.0
|
C
|
B:ASN421
|
3.6
|
57.2
|
1.0
|
CB
|
B:SER442
|
3.6
|
53.3
|
1.0
|
CE3
|
B:TRP417
|
3.6
|
45.9
|
1.0
|
CA
|
B:SER442
|
3.7
|
53.5
|
1.0
|
C
|
B:TRP417
|
3.7
|
55.6
|
1.0
|
N
|
B:GLY420
|
3.7
|
66.9
|
1.0
|
CB
|
B:LEU443
|
3.9
|
76.7
|
1.0
|
O
|
B:GLY420
|
3.9
|
60.3
|
1.0
|
CZ3
|
B:TRP417
|
3.9
|
45.2
|
1.0
|
C
|
B:SER442
|
4.0
|
57.4
|
1.0
|
CA
|
B:ASN421
|
4.0
|
60.0
|
1.0
|
CA
|
B:TRP417
|
4.0
|
53.0
|
1.0
|
CD2
|
B:TRP417
|
4.1
|
46.8
|
1.0
|
CE2
|
B:PHE423
|
4.2
|
41.5
|
1.0
|
O
|
B:ARG416
|
4.2
|
55.1
|
1.0
|
CA
|
B:LEU443
|
4.3
|
75.1
|
1.0
|
CD2
|
B:PHE423
|
4.5
|
41.5
|
1.0
|
CH2
|
B:TRP417
|
4.5
|
44.9
|
1.0
|
CG
|
B:TRP417
|
4.6
|
48.0
|
1.0
|
OG
|
B:SER442
|
4.7
|
51.2
|
1.0
|
CE2
|
B:TRP417
|
4.7
|
45.9
|
1.0
|
CB
|
B:ASN421
|
4.8
|
60.2
|
1.0
|
N
|
B:VAL422
|
4.8
|
53.2
|
1.0
|
CZ2
|
B:TRP417
|
4.9
|
44.8
|
1.0
|
CB
|
B:TRP417
|
4.9
|
50.6
|
1.0
|
C
|
B:GLN419
|
4.9
|
69.4
|
1.0
|
N
|
B:GLN418
|
5.0
|
60.6
|
1.0
|
|
Sodium binding site 9 out
of 9 in 5vu0
Go back to
Sodium Binding Sites List in 5vu0
Sodium binding site 9 out
of 9 in the Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 9 of Crystal Structure of the Complex Between Afucosylated/Galactosylated Human IGG1 Fc and Fc Gamma Receptor Iiia (CD16A) with MAN5 N-Glycans within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Na1014
b:39.9
occ:1.00
|
OE1
|
B:GLU357
|
2.6
|
45.5
|
1.0
|
N
|
B:SER354
|
3.2
|
45.2
|
1.0
|
NA
|
B:NA1011
|
3.3
|
40.3
|
1.0
|
CA
|
B:PRO353
|
3.5
|
41.6
|
1.0
|
CD
|
B:GLU357
|
3.7
|
50.0
|
1.0
|
CD2
|
A:LEU368
|
3.7
|
28.5
|
1.0
|
O
|
B:SER364
|
3.9
|
36.9
|
1.0
|
C
|
B:PRO353
|
3.9
|
42.7
|
1.0
|
CB
|
B:SER354
|
3.9
|
49.0
|
1.0
|
CD2
|
A:LEU351
|
3.9
|
35.6
|
1.0
|
CB
|
B:SER364
|
4.1
|
36.8
|
1.0
|
CD2
|
A:TYR349
|
4.1
|
35.7
|
1.0
|
CB
|
B:GLU357
|
4.1
|
51.1
|
1.0
|
CB
|
A:TYR349
|
4.1
|
33.4
|
1.0
|
CA
|
B:SER354
|
4.1
|
47.1
|
1.0
|
CB
|
B:PRO353
|
4.2
|
42.3
|
1.0
|
CG
|
A:TYR349
|
4.2
|
35.0
|
1.0
|
OE2
|
B:GLU357
|
4.5
|
50.9
|
1.0
|
CG
|
B:GLU357
|
4.5
|
50.5
|
1.0
|
O
|
B:PRO352
|
4.6
|
36.5
|
1.0
|
N
|
B:PRO353
|
4.6
|
40.7
|
1.0
|
C
|
B:SER364
|
4.7
|
36.1
|
1.0
|
OG
|
B:SER364
|
4.7
|
37.5
|
1.0
|
O
|
B:SER354
|
4.7
|
49.0
|
1.0
|
CA
|
B:SER364
|
4.8
|
36.8
|
1.0
|
N
|
B:SER364
|
4.8
|
38.6
|
1.0
|
CE2
|
A:TYR349
|
4.8
|
38.1
|
1.0
|
C
|
B:SER354
|
5.0
|
49.9
|
1.0
|
|
Reference:
D.J.Falconer,
G.P.Subedi,
A.M.Marcella,
A.W.Barb.
Antibody Fucosylation Lowers the Fc Gamma Riiia/CD16A Affinity By Limiting the Conformations Sampled By the N162-Glycan. Acs Chem. Biol. V. 13 2179 2018.
ISSN: ESSN 1554-8937
PubMed: 30016589
DOI: 10.1021/ACSCHEMBIO.8B00342
Page generated: Tue Oct 8 00:55:49 2024
|